Ajanta Pharma Ltd News
Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally
Individually, Cipla soared up to 3.68 per cent to hit an intraday high of Rs 1,547.70 per share, while Sun Pharma soared up to 3.30 per cent to hit an intraday high of Rs 1,791.60 per share
 "Nifty Pharma jumps over 2%: Analysts decode the drivers behind the rally")
Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%
Q1 earnings cheer: Lupin, Zydus Lifesciences, Glenmark Pharmaceuticals, Aurobindo Pharma, Torrent Pharmaceuticals and Sun Pharmaceutical were up between 2 per cent and 3 per cent.
 "Pharma shares rally; Suven, Granules, Ajanta, Jubilant surge over 5%")
Ajanta Pharma Q1 results: PAT up 18% to Rs 246 cr on robust sales
Ajanta Pharma on Tuesday said its consolidated profit after tax (PAT) increased 18 per cent year-on-year to Rs 246 crore for the June quarter, on account of robust sales across domestic and international markets. The drug firm had reported a profit after tax of Rs 208 crore in the April-June quarter of last fiscal. Revenue from operations rose to Rs 1,145 crore during the quarter under review as against Rs 1,021 crore in the year-go period, Ajanta Pharma said in a regulatory filing. The company said its India sales grew 10 per cent year-on-year to Rs 353 crore in the first quarter. The company's US sales grew 7 per cent to Rs 228 crore in the first quarter of the current fiscal. Shares of Ajanta Pharma ended 3.99 per cent up at Rs 2,524.35 apiece on the BSE.
 "Ajanta Pharma Q1 results: PAT up 18% to Rs 246 cr on robust sales")
